Gennova gets DCGI’s nod for developing Omicron-specific mRNA vaccine
Pune-based Gennova Biopharmaceuticals Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) for conducting a clinical trial of its mRNA vaccine, Gemcovac-19, against the Omicron variant of COVID19.
MoneyControl | October 10, 2022 / 04:12 PM IST